"Alliance Edition" Medical Consumables With Volume Procurement To Accelerate The Collection Of High Value Consumables Is Expected To Come Out.

"Enterprises are not afraid of price cuts, they are afraid of market chaos." In June 3rd, Shi Lichen, director of Beijing Ding Chen medical management consulting center, who was concerned about the quantity purchase, said in an interview with the twenty-first Century economic report that following the purchase of medical belt, the collection of medical consumables is accelerating.

According to a survey conducted by the economic news reporters in twenty-first Century, many provinces and cities have already issued procurement documents for medical consumables, part of which appears in the form of regional alliance, that is, the inter provincial alliance and inter city alliance. For example, the seven municipal medical and pharmaceutical safety bureau recently launched a joint purchase of medical supplies and purchase materials by the Zibo Municipal Medical Security Bureau.

"Now every place takes the lead to take quantity purchase, the price is not equal, the quantity cannot also guarantee, moreover carries on the tender in a place may disturb the medicine enterprise national price system, this is not the enterprise hoped to see the situation." Shi Lichen believes that there are many problems of collecting and mining, and the recurrence of tendering tenders should be unified by the state. It is also suggested that the relevant departments of the state carry out "looking back" in the field of quantity purchasing.

A person who has just attended Beijing, Tianjin, Hebei and Heiji, Liaoning, and 3+6 has reported to the twenty-first Century economic news reporter that he has won the bid, and is waiting for further rules for reimbursement of medical insurance. He disclosed that the 14 western provinces alliance and the Jiangsu, Zhejiang and Shanghai Alliance have collected basic information to enterprises, and the tender invitation for related procurement is about to begin.

"Alliance edition" procurement acceleration

In mid March, the National Health Insurance Bureau has explicitly requested that in the next 6 months (i.e. mid September), the 11 pilot provinces (Jiangsu, Anhui, Fujian, Qinghai, Shanghai, Zhejiang, Hunan, Chongqing, Sichuan, Shaanxi and Ningxia) will carry out the procurement of high-value consumables, and the remaining 23 provinces and cities should also actively follow up.

It is understood that there are now many provinces and municipalities (positive) organize medical consumables with quantity procurement. For example, in May 9th, the first batch of artificial lens ophthalmic consumables will be held in Tianjin. The nine provinces of Beijing, Tianjin, Hebei, Heibei, Kyrgyzstan, Liaoning, Mongolia, Shanxi and Shandong have jointly purchased artificial lens ophthalmic consumables. In May 21st, the Medical Security Bureau of Chongqing, Guizhou, Yunnan and Henan jointly issued a notice to organize centralized procurement of medical consumables. In May 25th, the Zhejiang pharmaceutical and equipment procurement center drew up the procurement document of some medical consumables in public health institutions of Zhejiang province (Draft).

From now on, many medical consumables are collected in the form of alliance. Wang Ying, head of Beijing Bo Ya Enterprise Management Consulting Co., Ltd., pointed out to the twenty-first Century economic report reporter that this is mainly to protect the volume of enterprises in the region.

Purchasing medical consumables is an inevitable trend. At present, high value consumables are being implemented everywhere, many of them are carried out in the form of alliance. The reason for starting with high value consumables is that they are relatively easy to make from pricing, materials, product matching and so on, while diagnostic reagents and other consumables also involve some screening diagnoses. Pricing is also difficult to achieve the same size, but the purchase of these consumables is also a matter of time. The head of a medical consumables enterprise told the twenty-first Century economic news reporter that the price reduction of medical consumables will not be small.

Recently, the Zibo Municipal Medical Security Bureau issued the announcement on the joint purchase of medical supplies in seven cities to list the selected enterprises and products. And the volume purchase is known as the "largest in history" in Shandong, "bargaining is super".

According to the twenty-first Century economic report, the Zibo Municipal Medical Insurance Bureau launched the seven municipal medicine and Equipment Procurement Alliance purchase price negotiation of medical consumables, involving 5 categories, 19 specifications of oxygen inhalation devices, syringes, blood sampling needles, catheters and catheterization packages, attracting more than 100 famous domestic and foreign enterprises to sign up, and finally confirmed 88 enterprises to participate in the negotiations.

The price of participating products is obvious. The market price of oxygen inhalation device of a manufacturer is 46 yuan, 12.9 yuan after haggle, a drop of 72%, which is the highest drop in consumables. According to the scene estimate, the blood needle's decline is about 50%, and other categories also have a larger decline.

The competition of high value consumables is no less than that of ordinary consumables. The above intraocular lens leader told the twenty-first Century economic news reporter that in the above 3+6 alliance procurement, after 9 days and two rounds of negotiations, the final procurement negotiations in May 18th came out, and nearly half of the artificial lens enterprises were eliminated. The total volume of procurement involves 313 thousand and 900 artificial lenses, the annual purchase amount is 934 million yuan, and the transaction price after negotiation is reduced by 292 million yuan.

"We have been more active in the procurement of the alliance, and have produced very sincere prices, because the alliance has promised volume to give us the opportunity to enter the market. Last year, Anhui and Jiangsu also purchased the consortium in the form of public medical institutions to carry out the quantity purchase of Department of orthopedics (Ji Zhu) and ophthalmic (intraocular lens) products, but there was no commitment, so the enthusiasm of the enterprises was not high at that time. The above artificial lens business executives said.

High value consumables national collection movement

"Procurement of medical consumables including high value consumables" is unavoidable. The collection and collection at provincial level and consortium continue to be carried out, and national collection is actively explored. Wang Ying told the economic news reporters in twenty-first Century.

Including the above two enterprises leaders believe that if the future alliance can get through, then the effect is actually equivalent to the whole country with quantity procurement.

Recently, a document published by the national health insurance price collection center on the procurement of three types of applied consumables has been published in the industry. It is submitted to the three categories of products, such as coronary stent, coronary balloon and intraocular lens (high value consumables), which are purchased from the provincial medical consumables collection platform in 2019.

According to an industry insider, the above documents are actually a collection document for national collection, and the relevant enterprise information has been collected and completed. In May 28th, the National Health Insurance Bureau posted a news conference on "Industry Forum on high-value medical consumables centralized procurement reform held by deputy director Chen Jinfu", but the industry believed that the 56 words had huge amount of information, and speculated that enterprises participating in the symposium or representatives of the three types of product enterprises in the above mentioned documents will be used as a pilot project for the collection of high value consumables in the three categories.

However, Chang Zhaohua, chairman of the CPPCC National Committee and chairman and chief executive officer of Shanghai minimally invasive medical care, suggested that the pilot procurement of high-value consumables should be suspended during the two sessions of the national conference this year. Chang Zhaohua believes that there is a lack of unified product quality evaluation system, and repeated procurement everywhere is a problem that can not be ignored in the procurement of high-value consumables. The development and innovation of high-end medical devices in China still needs strong support from the state.

Chang Zhaohua expressed the hope that the varieties that have been carried out with quantity purchase will no longer carry out repeated cross regional and cross alliance procurement. Based on the results of the pilot areas, a national linkage mechanism of high-value consumables has been gradually formed, including follow-up measures such as follow-up medical insurance payment standards and so on. It guides the clinical initiative to find and use the best price performance products, and avoid the vicious competition of "price and car wars" brought by repeated volume purchase.

Shi Lichen also told the twenty-first Century economic news reporter that there are some drawbacks in the local quantity purchase. It is suggested that the quantity purchase be taken as a whole from the national level. It is pointed out that at present, the medical insurance department is not very aware of the purchase and sale of the hospital (purchase, sale, stock), and it is also difficult to monitor the prescription of the doctor, which has a great impact on the landing of the quantity purchase.

To this end, Shi Lichen suggested that the National Health Insurance Bureau set up a large database to connect the products of the hospital health insurance catalogue to purchase and sell data, so that it can not only help the medical insurance bureau to determine the true quantity of purchases, but also clearly know the current usage of the quantity purchase products in hospitals, and at the same time, it can effectively monitor the prescription of doctors, so as to avoid doctors purchasing products with non quantity. But also can know whether the hospital timely reimbursement to pharmaceutical companies.

?